Wnt Agonist
|
|
|
- CAS-Nr.
- 853220-52-7
- Englisch Name:
- Wnt Agonist
- Synonyma:
- BML;BML-284;-284;AMBMP;CS-2376;Wnt Agonist;2-Amino-4-[3;Wnt agonist 1;Wnt Agonist I;BML-284 (BML 284
- CBNumber:
- CB42750501
- Summenformel:
- C19H18N4O3
- Molgewicht:
- 350.37
- MOL-Datei:
- 853220-52-7.mol
|
Wnt Agonist Eigenschaften
- Siedepunkt:
- 623.4±65.0 °C(Predicted)
- Dichte
- 1.353±0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- L?slichkeit
- DMSO: soluble20mg/mL, clear
- Aggregatzustand
- Yellowish sticky solid
- pka
- 6.62±0.10(Predicted)
- Farbe
- white to beige
- InChI
- 1S/C19H18N4O3/c1-24-14-4-2-3-13(8-14)15-9-18(23-19(20)22-15)21-10-12-5-6-16-17(7-12)26-11-25-16/h2-9H,10-11H2,1H3,(H3,20,21,22,23)
- InChIKey
- FABQUVYDAXWUQP-UHFFFAOYSA-N
- SMILES
- N(Cc3cc4c(cc3)OCO4)c1nc(nc(c1)c2cc(ccc2)OC)N
Wnt Agonist Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
CID 11210285 hydrochloride has been used as a Wnt agonist.
Biochem/physiol Actions
CID 11210285 is a cell-permeable, potent and selective activator of Wnt signaling without inhibiting GSK-3β. CID 11210285is a Wnt agonist.
Wnt Agonist Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Wnt Agonist Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 126)Lieferanten
853220-52-7()Verwandte Suche:
- AMBMP
- CID 11210285 hydrochloride
- N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-2,4-pyrimidinediamine hydrochloride
- Wnt agonist 1
- 2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine hydrochloride
- Wnt agonist 1 (BML-284)
- N4-(1,3-Benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-2,4-pyrimidinediamine
- Wnt Agonist
- Wnt Agonist I
- BML-284 (BML 284
- CS-2376
- Wnt Agonist - CAS 853220-52-7 - Calbiochem
- Wnt Agonist I in DMSO - CAS 853220-52-7 - Calbiochem
- BML-284 (Wnt agonist 1)
- Wnt agonist 1 hydrochloride
- 2-Amino-4-[3
- 4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl)pyrimidine
- BML-284;2-AMINO-4-[3;4-(METHYLENEDIOXY)BENZYLAMINO]-6-(3-METHOXYPHENYL)PYRIMIDINE
- CID 11210285 HCL（BML-284 HCl）
- -284
- 2,4-Pyrimidinediamine, N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)-
- BML-284 HCl，Wnt Agonist
- N-cadherin,E-cadherin,malformed phenotype,BML 284,Wnt,inhibit,AGS,BML284,BML-284,TCF,Inhibitor,cardiac defect,MNK45
- N4-[(2H-1,3-benzodioxol-5-yl)methyl]-6-(3-methoxyphenyl)pyrimidine-2,4-diamine
- BML 284, Wnt signaling activator
- BML-284, 10 mM in DMSO
- Wnt Agonist I in DMSO
- BML
- BML-284
- 853220-52-7
